- Home
- EVRI vs AVDL Comparison
EVRI vs AVDL Comparison
Compare EVRI & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVRI
- AVDL
- Stock Information
- Founded
- EVRI 1998
- AVDL 2015
- Country
- EVRI United States
- AVDL Ireland
- Employees
- EVRI N/A
- AVDL N/A
- Industry
- EVRI Services-Misc. Amusement & Recreation
- AVDL Biotechnology: Pharmaceutical Preparations
- Sector
- EVRI Consumer Discretionary
- AVDL Health Care
- Exchange
- EVRI Nasdaq
- AVDL Nasdaq
- Market Cap
- EVRI 1.2B
- AVDL 993.5M
- IPO Year
- EVRI 2005
- AVDL 1996
- Fundamental
- Price
- EVRI $13.50
- AVDL $10.48
- Analyst Decision
- EVRI Hold
- AVDL Strong Buy
- Analyst Count
- EVRI 5
- AVDL 6
- Target Price
- EVRI $12.88
- AVDL $24.00
- AVG Volume (30 Days)
- EVRI 517.2K
- AVDL 1.1M
- Earning Date
- EVRI 01-07-2025
- AVDL 11-12-2024
- Dividend Yield
- EVRI N/A
- AVDL N/A
- EPS Growth
- EVRI N/A
- AVDL N/A
- EPS
- EVRI 0.15
- AVDL N/A
- Revenue
- EVRI $760,419,000.00
- AVDL $138,160,000.00
- Revenue This Year
- EVRI N/A
- AVDL $523.86
- Revenue Next Year
- EVRI $5.06
- AVDL $70.46
- P/E Ratio
- EVRI $90.53
- AVDL N/A
- Revenue Growth
- EVRI N/A
- AVDL 1523.50
- 52 Week Low
- EVRI $6.37
- AVDL $9.41
- 52 Week High
- EVRI $13.53
- AVDL $19.09
- Technical
- Relative Strength Index (RSI)
- EVRI 61.61
- AVDL 46.37
- Support Level
- EVRI $13.46
- AVDL $9.97
- Resistance Level
- EVRI $13.53
- AVDL $10.53
- Average True Range (ATR)
- EVRI 0.03
- AVDL 0.47
- MACD
- EVRI -0.00
- AVDL 0.12
- Stochastic Oscillator
- EVRI 68.75
- AVDL 61.43
About EVRI Everi Holdings Inc.
Everi Holdings Inc provides entertainment and technology solutions for the casino, interactive, and gaming industry. It operates in two segments namely Games and Financial Technology Solutions (FinTech). Enveri Games provides gaming operators with gaming technology products and services which include gaming machines, slot machines, leased gaming equipment, and other products and services. Enveri FinTech provides gaming operators with financial technology products and services which include services and equipment that facilitate casino patron's to access cash at gaming facilities through automated teller machines, point of sale debit card purchases and others.
About AVDL Avadel Pharmaceuticals plc
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.